Evidence map›Paper›PMID 31447959›Full record

ArticleJournal of solid tumors2019

Differential expression of efferocytosis and phagocytosis associated genes in tumor associated macrophages exposed to African American patient derived prostate cancer microenvironment.

Hirendra Banerjee, Christopher Krauss, Myla Worthington, Narendra Banerjee, Ray Shawn Walker, Sasha Hodges, Lin Chen, Kuldeep Rawat, Santanu Dasgupta, Somiranjan Ghosh and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of solid tumors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Hirendra BanerjeeNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Christopher KraussNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Myla WorthingtonNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Narendra BanerjeeNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Ray Shawn WalkerNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Sasha HodgesNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Lin ChenNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Kuldeep RawatNatural, Pharmacy and Health Sciences Department, Elizabeth City State University, University of North Carolina, Elizabeth City, United States.
Santanu DasguptaDepartment of Pediatrics & Child Health, The University of Texas Health Science Center at Tyler, Tyler, United States.
Somiranjan GhoshInternal Medicine Department, Howard University, Washington D.C, United States.
Santosh MandalChemistry Department, Morgan State University, Baltimore, United States.
Elizabeth City State University · USHoward University · USMorgan State University · USThe University of Texas Health Science Center at Tyler · US

Funding

PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Elizabeth City State University Minority Access to Research Careers (E-MARC) UndeT34GM100831 · NIGMS · ELIZABETH CITY STATE UNIVERSITY · PI BANERJEE, HIRENDRA N · 2012 to 2022
$1.9M
NIGMS NIH HHS T34 GM100831NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

Macrophages are the first line of defense in the cellular environment in response to any antigenic or foreign invasion. Since cancer cells express antigenic molecules and create a tumor microenvironment quite different from the normal cellular environment, macrophages will attack this cancer cells as foreign Invaders. However, the cancer cells adept their ability to suppress macrophage activity by secreting compounds/proteins through unknown mechanisms and train these macrophages to aid in tumorigenesis. These macrophages are commonly known as tumor associated macrophages (TAM). In this study, our goal was to find out key regulatory molecules involved in this conversion of cancer-fighting macrophages to cancer friendly macrophages. We used African American(AA) patient derived established human prostate cancer cells along with the human derived macrophages followed by Affymetrix cDNA microarray analysis. Microarray analysis of the PCa cell exposed macrophages revealed appreciable decrease in mRNA expression of several genes associated with phagocytosis process. Aberrant expression of several noncoding RNAs that control the expression of such phagocytosis associated molecules were also evident. Increased expression of oncogenic miR such as, miR-148, 615, 515, 130, 139 and markedly decreased expression of tumor suppressive miR's MiR-3130, let7c,101,103, 383 were noted. Further, TARGET SCAN analysis demonstrated these differential expression of non-coding RNA's causing down regulation of phagocytosis promoting genes elf5A, Meg3, Tubb5, Sparcl-1, Uch-1, Bsg(CD147), Ube2v, GULP, Stabilin 1 and Pamr1. There is an increase of RAP1GAP gene that causes concomitant decrease in the expression of tubulin genes that promote cytoskeletal assembly in forming phagosomes. In addition Ingenuity pathway analysis of the gene expression data also showed upregulation of antiphagocytic genes IL-10, CD 16, IL-18 and MMP-9. Some core canonical pathways showing physiology of cellular signaling obtained by data analyzed by the Ingenuity software is confirmed a very complex mechanism still to be deciphered involved in the biology of TAM formation by which the rogue cancer cells tame their enemies, the macrophages and actually make them their helper cells to survive and propagate in the tumor microenvironment and thus prepare for epithelial mesenchymal transition for future metastasis and cancer stem cell formation and progression.

Indexed as

Core canonical pathwaysTumor associated macrophagesTumor microenvironment

Identifiers

PMID31447959
PMCPMC6707537
OpenAlexW2953413417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.